European alternatives to Examine
Examine built the web's authoritative supplement research database and then raised a $12M Series A to scale it. European supplement researchers, practitioners, and informed consumers leave because Examine is US-owned, US-hosted, and lacks the regulatory-context specificity that EU practitioners need to navigate 27 separate member-state supplement classification schemes.
Examine's 1000+ supplement monographs compile peer-reviewed studies with systematic rigor. No competitor in the EU has replicated that depth of coverage or citation density. This is Examine's structural advantage. Yet that advantage creates a problem for European practitioners: Examine's evidence base is largely drawn from studies conducted in North American populations on supplements approved under US FDA frameworks. When a French pharmacist or German sports nutritionist needs to know whether a given ingredient meets EFSA Novel Food regulations, or which EU member states permit it as a food supplement versus requiring it as a medicinal product authorization, Examine provides the raw evidence but not the jurisdictional answer. A supplement legal in Germany (by BfArM approval as a traditional herbal product under the THMPD) may be prohibited in Belgium, or delisted in France after the ANSM removed it from the positive list. Examine's monographs do not surface these member-state-level regulatory differences, forcing practitioners to cross-reference separately with national competent authorities. The second friction point is data residency and client privacy. Examine stores all research, client accounts, and query data on US servers, which triggers GDPR compliance friction for EU institutional buyers (hospitals, research institutes, insurance companies) who require verified EU-resident data processing and custodianship. For individual practitioners or consumers in GDPR-regulated sectors, Examine's data-residency ambiguity creates legal defensibility questions.
Where each alternative is built, owned and hosted
Read the billing unit, deployment scope and supporting evidence. Missing documentation is not a negative finding. On small screens, scroll the table sideways.
| Product | Pricing and billing unit | Data and deployment scope | Self-hosting / Source code |
|---|---|---|---|
| ESCOP MonographsView evidence → | Catalog information: FreemiumNot documented here | Not documented here | Self-hosting Not documented hereSource code Not documented here |
| Informed Choice (LGC)View evidence → | Catalog information: FreemiumNot documented here | Not documented here | Self-hosting Not documented hereSource code Not documented here |
| Kosttillskottsguidenby the founderView evidence → | Catalog information: FreeNot documented here | Not documented here | Self-hosting Not documented hereSource code Not documented here |
| Pharmaceutical Press Herbal Medicines and Dietary SupplementsView evidence → | Catalog information: ContactNot documented here | Not documented here | Self-hosting Not documented hereSource code Not documented here |
| PHYDGIView evidence → | Catalog information: ContactNot documented here | Not documented here | Self-hosting Not documented hereSource code Not documented here |
| Stiftung WarentestView evidence → | Catalog information: FreemiumNot documented here | Not documented here | Self-hosting Not documented hereSource code Not documented here |
| Supplement-Bewertung.deView evidence → | Catalog information: FreeNot documented here | Not documented here | Self-hosting Not documented hereSource code Not documented here |
| Supplemento.deView evidence → | Catalog information: FreemiumNot documented here | Not documented here | Self-hosting Not documented hereSource code Not documented here |

ESCOP Monographs
gbEuropean scientific consensus on herbal medicinal products for healthcare professionals and researchers.
- Catalog information

Informed Choice (LGC)
gbThird-party certification and testing for dietary supplement safety and quality assurance.
- Catalog information

Kosttillskottsguiden
seGuide to dietary supplements, in Swedish.
- Catalog information

Pharmaceutical Press Herbal Medicines and Dietary Supplements
gbEvidence-based reference tool for herbal medicines and dietary supplements integrated within MedicinesComplete platform.
- Catalog information

PHYDGI
frA validated herb-drug interaction database developed by French research institutions and integrated into clinical prescribing workflows.
- Catalog information

Stiftung Warentest
deGermany's trusted independent product testing foundation delivering unbiased consumer research since 1964.
- Catalog information

Supplement-Bewertung.de
deIndependent German supplement testing platform delivering science-backed reviews and honest product evaluations.
- Catalog information

Supplemento.de
deIndependent scientific assessment platform for dietary supplement quality and efficacy.
- Catalog information
Our honest take
For EU researchers and academic nutritionists who need population-specific efficacy data and don't require regulatory-pathway guidance, Examine is still the credible source—it has no EU equivalent on citation density and study design rigor. No reasonable substitution exists for its monograph depth. For practitioners needing EFSA-aligned supplement classification and member-state regulatory context, EuroFIR (Belgium, non-profit, 26+ EU countries' food composition data plus eBASIS plant bioactives database) is the closest functional match: it provides harmonized, government-backed nutrient data across EU jurisdictions, though it lacks Examine's study-by-study evidence base and is aimed at researchers and institutional members, not individual practitioners. For sports nutritionists and fitness professionals in the EU wanting rigorous, science-backed supplement guidance, Supplement-Bewertung.de (Germany, independently funded, hands-on testing of 75% of reviewed products, EFSA citations over marketing claims) and DiSE (Deutsches Institut für Sporternährung, Germany, science-backed certification, specializes in translating human studies into practitioner guidance) both offer Examine-like rigor but with EU-specific regulatory and practical context. Supplemento.de (Germany, cooperative ownership, 60+ scientific criteria, real-time interaction checker) serves practitioners needing personalized supplement recommendations and client safety checking; it includes drug-nutrient interaction detection that Examine does not expose. Pharma Nord (Denmark, 300+ clinical trials, manufactured under pharmaceutical GMP standards since 1981) suits practitioners and consumers who prioritize clinical documentation and bioavailability—it is a supplement brand AND a research publisher, not a generic evidence resource like Examine. For institutional buyers requiring EU data residency, Tentamus Group (Germany, 96 accredited labs, comprehensive testing, GDPR-compliant) and Eurofins Scientific (global but GDPR-contractual, 950+ labs) both provide testing and regulatory compliance verification that Examine never attempted. Kosttillskottsguiden (Sweden, free, EU-hosted, evidence-based, Swedish language) is credible for Swedish-speaking users wanting a lightweight alternative to Examine's depth—it covers fewer supplements and cites fewer studies, but those it includes are evidence-checked and the data stays in the EU. Kosttillskottsguiden is not a Examine replacement; it is a narrower resource for EU consumers prioritizing data residency over comprehensive coverage. Examine wins on evidence depth, citation density, and monograph breadth. Examine loses on member-state regulatory specificity, data residency for institutional GDPR compliance, and practical integration of EU-specific supplement classification rules.
Related European alternatives
Browse related categories
What we compare
- Where the data is stored
- Who owns the company
- Documented data and deployment scope
- Self-hosting option
- Open source
- Pricing model